The molecular test that avoids unnecessary surgeries
ThyroidPrint resolves the diagnostic uncertainty of indeterminate thyroid nodules with Bethesda III and IV category.
#SaveThyroids
WHAT IS THYROIDPRINT?
A molecular test that works with you
ThyroidPrint is a molecular test capable of resolving the diagnostic uncertainty of indeterminate thyroid nodules (Bethesda III or IV). To perform the test, a thyroid FNA is performed, which is analyzed by real-time PCR. Subsequently, results are processed through neural-network algorithm which provides a score that determines whether the nodule is benign or not.
A globally recognized test to improve your quality of life
ThyroidPrint is a validated test in the United States and Latin America, created by the GeneproDX laboratory. Its goal is to change the way indeterminate thyroid nodules are diagnosed and treated worldwide.
Scientific evidence
Check out the scientific evidence supporting the high performance of ThyroidPrint here.
ThyroidPrint in numbers
Centers collaborating with us
America
[elementor-template id=”4502″]
[elementor-template id=”4482″]
[elementor-template id=”4492″]
[elementor-template id=”4487″]
[elementor-template id=”5848″]
[elementor-template id=”6091″]
[elementor-template id=”6755″]
[elementor-template id=”6762″]
PATIENTS!
Criteria to select a patient that could benefit from ThyroidPrint testing?
A patient with an indeterminate thyroid nodule (Bethesda III or IV).
The indeterminate nodule with a size 8 millimeters or greater.
The patient 18 years or older (for patients under 18 years old it should be analyzed case by case).
Authorizations and Accreditations
Our laboratory is accredited by the College of American Pathologists (CAP), considered internationally the highest standard of quality accreditation for clinical laboratories worldwide.
Recognitions
ThyroidPrint has been recognized with multiple awards. We invite you to see some of these moments.
Partners
